Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis

BACKGROUND: The elevated calcium and phosphorus levels in patients undergoing hemodialysis may increase the risk of all-cause mortality. Paricalcitol, as a new vitamin D receptor activator (VDRA), seemed to be effective in reducing the calcium and phosphorus levels. OBJECTIVES: The aim of this study...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drug Des Devel Ther
Main Authors: Liu, Yang, Liu, Ling-Yun, Jia, Ye, Wu, Mei-Yan, Sun, Yan-Yan, Ma, Fu-Zhe
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2019
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6445244/
https://ncbi.nlm.nih.gov/pubmed/30992658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S176257
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker